This was pointed out by experts at the summer course "Vaccines for the XXI Century" of the Universidad Internacional Menéndez Pelayo (UIMP) in collaboration with the Study Group on Adult Immunization (Gesves). To this end, new technologies capable of providing specific molecular patterns, play an essential role.

According to Ramón Cisterna, course director and coordinator of Gesves, "in the near future, vaccines that will cure a reality." Benito Regueiro, Professor of Microbiology and Head of Service of Microbiology, Hospital Clínico de Santiago de Compostela, has been advanced that "they are investigating vaccines for diseases such as rheumatoid arthritis, Alzheimer's and even high blood pressure, for example, case of autoimmune myocarditis has been observed that treatment with a special vaccine enhances the severity of the disease. "

"We seek solutions for both new targets and to tackle old problems remain unanswered such as tuberculosis and influenza epidemics."

The development of this research is based on improved scientific understanding of the body's defense system, and the memory performance of defense, together with the development of genomic and proteomic technologies. It is technologically possible to educate dendritic cells responsible for recognition.

Vaccines traditionally seek to prepare the body to respond effectively when an illness, but now, because they better understand the cells involved in this and have technological methods, technology can educate these cells to give a more effective response.

All this is achieved by extracting cells of the individual, training them to respond and re-inserted in the body to be achieved not only immunize against a virus but also against many other diseases.